Paper33808293
Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma.
Lopes J and 11 others. Biomolecules, 2021. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma. Papers, record 33808293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33808293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Low-Level Light Therapy | Major topic |
| Melanoma | Major topic |
| Multifunctional Nanoparticles | Major topic |
| Skin Neoplasms | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Epidermal Growth Factor | |
| Gold | |
| Humans | |
| Male | |
| Metal Nanoparticles | |
| Mice, SCID | |
| Oleic Acid | |
| Proof of Concept Study | |
| Xenograft Model Antitumor Assays | |
| Mice |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| SFRH/BD/148044/2019 and SFRH/BD/147306/2019 | FCT | PubMed | ||
| PTDC/BBB-BMC/0611/2012, 551 UIDB/00645/2020, UIDB/04138/2020 and UIDP/04138/2020 | FCT | PubMed |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33353068 | A Step Forward in Breast Cancer Research: From a Natural-Like Experimental Model to a Preliminary Photothermal Approach. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33353068 | PubMed |
| 2 | 20679910 | Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation. | Melanoma Res | 2010 | https://conductscience.org/library/papers/20679910 | PubMed |
| 3 | 19891496 | RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy. | Mol Pharm | 2010 | https://conductscience.org/library/papers/19891496 | PubMed |
| 4 | 28223185 | Nanomedicine as a potent strategy in melanoma tumor microenvironment. | Pharmacol Res | 2017 | https://conductscience.org/library/papers/28223185 | PubMed |
| 5 | 27788212 | EGF Functionalized Polymer-Coated Gold Nanoparticles Promote EGF Photostability and EGFR Internalization for Photothermal Therapy. | PLoS One | 2016 | https://conductscience.org/library/papers/27788212 | PubMed |
| 6 | 19447870 | Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19447870 | PubMed |
| 7 | 9219503 | Human tumor models in the severe combined immune deficient (scid) mouse. | Cancer Chemother Pharmacol | 1997 | https://conductscience.org/library/papers/9219503 | PubMed |
| 8 | 29562135 | Cellular Uptake of Gold Nanoparticles Triggered by Host-Guest Interactions. | J Am Chem Soc | 2018 | https://conductscience.org/library/papers/29562135 | PubMed |
| 9 | 31931389 | Size-dependent apoptotic activity of gold nanoparticles on osteosarcoma cells correlated with SERS signal. | J Photochem Photobiol B | 2020 | https://conductscience.org/library/papers/31931389 | PubMed |
| 10 | 26884153 | Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/26884153 | PubMed |
| 11 | 19052619 | Efficient tumour formation by single human melanoma cells. | Nature | 2008 | https://conductscience.org/library/papers/19052619 | PubMed |
| 12 | 27125352 | From melanocytes to melanomas. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27125352 | PubMed |
| 13 | 23089470 | Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line. | Biomed Pharmacother | 2012 | https://conductscience.org/library/papers/23089470 | PubMed |
| 14 | 26451914 | In Vitro and In Vivo Tumor Targeted Photothermal Cancer Therapy Using Functionalized Graphene Nanoparticles. | Biomacromolecules | 2015 | https://conductscience.org/library/papers/26451914 | PubMed |
| 15 | 22993143 | Genetically engineered cancer models, but not xenografts, faithfully predict anticancer drug exposure in melanoma tumors. | Oncologist | 2012 | https://conductscience.org/library/papers/22993143 | PubMed |
| 16 | 28426435 | Surface plasmon resonance in gold nanoparticles: a review. | J Phys Condens Matter | 2017 | https://conductscience.org/library/papers/28426435 | PubMed |
| 17 | 31753105 | Epidemiology and Risk Factors of Melanoma. | Surg Clin North Am | 2020 | https://conductscience.org/library/papers/31753105 | PubMed |
| 18 | 12438452 | Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cells. | J Clin Invest | 2002 | https://conductscience.org/library/papers/12438452 | PubMed |
| 19 | 28078340 | Biocompatible CuS-based nanoplatforms for efficient photothermal therapy and chemotherapy in vivo. | Biomater Sci | 2017 | https://conductscience.org/library/papers/28078340 | PubMed |
| 20 | 31694306 | Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31694306 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926737 | Targeted photodynamic therapy for colorectal cancer using antibody-conjugated green-synthesised nanoparticles. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42926737 | PubMed |
| 42794589 | Overcoming Biophysical Barriers in Melanoma Photomedicine: From Photodynamic Therapy to Smart Nanodelivery and Photoimmunotherapy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794589 | PubMed |
| 42511737 | Photodynamic Therapy for Keratinocytic Precancerous Lesions and Non-Melanoma Skin Cancer: A Narrative Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511737 | PubMed |
| 42428967 | Gold Nanoplatforms for Phenotypic Reprogramming and Closed-Loop Theranostics of Cancer Stem Cells. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42428967 | PubMed |
| 39940134 | Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/39940134 | PubMed |
| 39833557 | Recent advances in improved efficacies of gold nano-formulations in treatment of skin cancer: a systematic review. | Arch Dermatol Res | 2025 | https://conductscience.org/library/papers/39833557 | PubMed |
| 39314189 | Targeting superficial cancers with gold nanoparticles: a review of current research. | Ther Deliv | 2024 | https://conductscience.org/library/papers/39314189 | PubMed |
| 39065597 | Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39065597 | PubMed |
| 38674073 | A Step Forward for the Treatment of Localized Prostate Cancer Using Gold Nanoparticles Combined with Laser Irradiation. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38674073 | PubMed |
| 37111608 | Safety of Gold Nanoparticles: From In Vitro to In Vivo Testing Array Checklist. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111608 | PubMed |
| 36722207 | Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation. | Aesthet Surg J | 2023 | https://conductscience.org/library/papers/36722207 | PubMed |
| 36635761 | Advancements in nanoparticle-based treatment approaches for skin cancer therapy. | Mol Cancer | 2023 | https://conductscience.org/library/papers/36635761 | PubMed |
| 36551565 | Current Insights and Progress in the Clinical Management of Head and Neck Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36551565 | PubMed |
| 36230575 | Melanoma Management: From Epidemiology to Treatment and Latest Advances. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230575 | PubMed |
| 36145569 | How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36145569 | PubMed |
| 36005086 | Biological Thermal Performance of Organic and Inorganic Aerogels as Patches for Photothermal Therapy. | Gels | 2022 | https://conductscience.org/library/papers/36005086 | PubMed |
| 35547773 | Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment. | Theranostics | 2022 | https://conductscience.org/library/papers/35547773 | PubMed |
| 35053219 | The Role of Rosmarinic Acid on the Bioproduction of Gold Nanoparticles as Part of a Photothermal Approach for Breast Cancer Treatment. | Biomolecules | 2022 | https://conductscience.org/library/papers/35053219 | PubMed |
| 34924904 | An update of advanced nanoplatforms for Glioblastoma Multiforme Management. | EXCLI J | 2021 | https://conductscience.org/library/papers/34924904 | PubMed |
| 34831311 | The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval. | Cells | 2021 | https://conductscience.org/library/papers/34831311 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33808293
GET https://conductscience.org/api/papers/v1/33808293/references?page=2